...
首页> 外文期刊>Archives of disease in childhood. Education and practice edition >Codeine in paediatrics: pharmacology, prescribing and controversies
【24h】

Codeine in paediatrics: pharmacology, prescribing and controversies

机译:关于儿科的可待因:药理学,处方和争议

获取原文
获取原文并翻译 | 示例
           

摘要

Codeine is a drug that until recently was widely used in children. It was endorsed by the WHO as the second step on the analgesic ladder for cancer pain and has been used routinely for postoperative and breakthrough pain. Recently, its safety and efficacy have been called into question, following deaths after adenotonsillectomy was associated with its use. This has led to regulation by the US Food and Drug Administration, European Medicines Agency and the UK Medicines and Healthcare products Regulatory Agency to place significant restrictions on its use, and some centres have stopped using it altogether.
机译:可待因是一种药物,直到最近被广泛用于儿童。 作为癌症疼痛的镇痛阶梯的第二步,它是由患者的第二步认可的,并且已经常规用于术后和突破性的疼痛。 最近,它的安全性和有效性被调查了问题,在腺型切除术后死亡术后死亡与其使用相关。 这导致了美国食品药品管理局,欧洲药品局和英国药品和医疗保健制品监管机构的规定,以对其使用进行重大限制,其中一些中心完全停止使用它。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号